APA (7th ed.) Citation

Tebaibia, A., Mammeri, A., Brahimi, H., Ammi, M., AitSaid, N., Lebdjiri, M., . . . Bouabana, F. (2022). EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed during the First 6 Months of the Epidemic. Value in Health, 25(7), S434. https://doi.org/10.1016/j.jval.2022.04.756

Chicago Style (17th ed.) Citation

Tebaibia, A., et al. "EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed During the First 6 Months of the Epidemic." Value in Health 25, no. 7 (2022): S434. https://doi.org/10.1016/j.jval.2022.04.756.

MLA (9th ed.) Citation

Tebaibia, A., et al. "EPH3 Diabetes and the COVID-19 Epidemic in Algeria: Prevalence and Characteristics of Patients Diagnosed During the First 6 Months of the Epidemic." Value in Health, vol. 25, no. 7, 2022, p. S434, https://doi.org/10.1016/j.jval.2022.04.756.